Osprey Medical: Receives CE Marking approval for DyeVert Power XT

  • Osprey Medical (OSP) has received CE Marking approval for its second-generation DyeVert Power XT device
  • This approval means the product can now marketed and sold across Europe, which aligns with the company’s strategy
  • The main feature of the new device is its compatibility with automated power injectors
  • Monitoring the amount of dye used is important in reducing a patient’s risk for dye-related kidney damage
  • A recently published study by Dr Carlo Briguori found a 38 per cent dye reduction in patients who received DyeVert compared to the no-DyeVert group
  • Company shares are up 8.57 per cent and trading for 3.8 cents
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

New York Suits Coinbase and Gemini Over Prediction Markets

The state targets two major crypto exchanges regarding regulatory compliance.Highlights: New York has filed lawsuits against Coinbase and...

Cash App Strengthens Parental Control with Managed Accounts for Kids

New feature allows parents to set up and oversee accounts for their children.Highlights: Cash App introduces parent-managed accounts...

Visa and TikTok Launch Creator Card, Enhancing Monetization for Influencers

New financial tool aims to streamline earnings for content creators.Highlights: Visa and TikTok have launched the new Creator...

Nium and Coinbase Strengthen Global Stablecoin Settlement Partnership

The collaboration aims to enhance cross-border payments using stablecoins.Highlights: Nium partners with Coinbase to optimize stablecoin settlements.The collaboration...